Effectiveness of interventions to decrease hesitancy. by Maximilian Nicolaus Burger (12969212)

Adenosine inhibits AMPA EPSCs by decreasing presynaptic glutamate release. by Shouping Wang (402959)

DART-ID decreases missing datapoints across runs. by Albert Tian Chen (6900215)

“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”

Targeted point mutation (F639A) in the GluN1 subunit decreases ethanol sensitivity of NMDA receptors. by Carolina R. den Hartog (484817)

Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

“…HEK293T cells were transfected with control or C9orf72 shRNA for 72 hours before treatment. Cells were starved for 50 min before being supplemented with amino acids for 10–20 min prior to lysate collection. …”

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

Caspase-9 silencing decreases the expression of neuronal markers in differentiating NT2 cells. by Giuseppa Pistritto (299715)

“…<p>NT2 cells stably transfected with scrambled si-RNA or with caspase-9 si-RNA (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0036002#s2" target="_blank">Material and Methods</a> section) were harvested at the indicated time points during RA treatment. …”

Changes in the concentration of IL-10 in each group at different time points after injury (). by Yanlin Zou (12415810)

Subjects:

Data_Sheet_1_Switching to second line MS disease-modifying therapies is associated with decreased relapse rate.PDF by James John Marriott (16935942)

ChAT knock-down using an antisense oligodeoxynucleotide (AS-ODN) against ChAT, and decreased expression of ChAT in the DRG and spinal cord by Misaki Matsumoto (52354)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Decrease in BAL IL-10 after thoracic trauma. by Jürg Hamacher (80081)

Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

“…Arrows highlight examples of Tbr2+ cells outside the VZ, while arrowhead point to Tbr2+ cells still in the VZ. Tbr2+ cells have decreased d2EGFP signal in both the VZ and SVZ. …”

TR4 and TR9 decrease hepatoma cell viability at a lower TC50 than Sorafenib, SAHA or 5-Fluorouracil. by Nicole Lange (335740)

SDG decreases iron-induced apoptosis in H9c2 cells. by Stephanie Puukila (568109)

HAOSMCs lacking CD9 display altered actin arrangement and a decrease in active RhoA and collagen gel contraction. by Michael J. Herr (428546)

Regions of significantly decreased ACM of SP-MS relative to RR-MS patients. by Mark Lyksborg (583318)

Adhesion strength is decreased in NEDD9−/− MEFs. by Jessie Zhong (171961)

Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

“…<p>(a) Left: noise-evoked activity rates at different noise intensities for chronically tracked PPys cells in baseline and repeated stress conditions (<i>N</i> = 5 mice, <i>n</i> = 285 neurons, mean ± SE). Activity rates decreased during repeated stress compared to baseline (2-way ANOVA, condition F = 185.6, <i>p</i> = 4.8 × 10⁻⁴², condition: intensity interaction F = 10.37, <i>p</i> = 9.3 × 10⁻²¹, nested ANOVA (mouse nested within session), condition F = 174, <i>p</i> = 1.5 × 10⁻³⁹, condition: intensity interaction F = 12.7, <i>p</i> = 2 × 10⁻²⁶, post hoc for each level baseline versus repetitive stress <i>p</i> < 0.01 for all levels above 50 dB, all Bonferroni corrected). …”